Matches 151 - 200 out of 297 < 1 2 3 4 5 6 >


Match Document Document Title
US20080014252 TOPICAL COMPOSITIONS WITH LONG LASTING EFFECT  
Topical pharmaceutical formulations and compositions for transdermal delivery of a variety of active agents are described. The formulations and compositions are formulated to provide a long...
US20110033540 POLYMER FORMULATIONS FOR DELIVERY OF BIOACTIVE AGENTS  
Disclosed in the present application are compositions comprising a bioresorbable polymer matrix and a bio active agent, wherein the bioactive agent is dispersed within polymer matrix as a solid....
US20110144071 CRYSTALLINE ACTIVE INGREDIENT MICROPARTICLES, METHOD FOR PRODUCING THE SAME AND USE THEREOF IN DRUGS  
A method for producing highly crystalline and stable microparticles of an active substance with a very narrow size distribution. The microparticles being crystallized out of a suspension made of...
US20090263444 Fluocinolone Formulations in a Biodegradable Polymer Carrier  
Effective treatments of pain and inflammation are provided. Through the administration of an effective amount of fluocinolone at or near a target site, one can reduce, prevent or treat...
US20110160167 Steroid Derivatives Acting As Glucocorticosteroid Receptor Agonists  
The present invention provides compounds of formula (I) wherein n, p, R1, R2, X1, X2, X3, R3a, R3b, R4, R5 and R6 are as defined in the specification, a process for their preparation,...
US20140179650 PHARMACEUTICAL FORMULATION COMPRISING CICLESONIDE  
The invention relates to the field of medicine, in particular to the field of veterinary medicine. The invention relates to a pharmaceutical (medicament) formulation of glucocorticoids, especially...
US20150202156 DRY POWDER PHARMACEUTICAL COMPOSITION, ITS PREPARATION PROCESS AND STABLE AQUEOUS SUSPENSION OBTAINED FROM SUCH COMPOSITION  
Pharmaceutical composition in a dry powder form comprising at least one hydrophobic active principle, at least one water-soluble excipient and at least one surfactant, wherein the particles in...
US20090264391 Fluocinolone Implants to Protect Against Undesirable Bone and Cartilage Destruction  
Effective treatments for protecting against undesirable macrophage activity are provided. Through the administration of an effective amount of fluocinolone at or near a target site, one can reduce...
US20090298803 PHARMACEUTICAL COMPOSITION COMPRISING FLUOCINONIDE  
The present invention provides a composition, comprising fluocinonide in a vehicle comprising one or two penetration enhancers, solvents and emulsifiers wherein penetration enhancers are present...
US20080027034 Ciclesonide and Syk Inhibitor Combination and Method of Use Thereof  
The invention relates to pharmaceutical formulations containing combinations of ciclesonide and a syk inhibitor and the use of such pharmaceutical compositions in medicine, in particular in the...
US20130287819 BIOADHESIVE POLYMER-BASED CONTROLLED-RELEASE SYSTEMS, PRODUCTION PROCESS AND CLINICAL USES THEREOF  
The invention relates to release systems based on bioadhesive polymers, their manufacturing process and to their uses in the medical, pharmaceutical, cosmetic, cosmeceutical and nutraceutical...
US20140336160 NOVEL GLUCOCORTICOLD RECEPTOR AGONISTS  
This invention relates to novel glucocorticoid receptor agonists of formula (I): and to processes and intermediates for their preparation. The present invention also relates to pharmaceutical...
US20110182857 Delivery of Drugs to Mucosal Surfaces  
Liquid pharmaceutical compositions for administration to a mucosal surface, including a therapeutic agent and a pectin with a low degree of esterification are described. Such compositions gel, or...
US20150056279 Controlled Release and Taste Masking Oral Pharmaceutical Compositions  
The invention relates to tablet comprising granules dispersed in at least one hydrophilic compound or matrix. The granules contain an active agent, at least one amphiphilic compound and at least...
US20140302143 Controlled Release and Taste Masking Oral Pharmaceutical Compositions  
The invention relates to tablet comprising granules dispersed in at least one hydrophilic compound or matrix. The granules contain an active agent, at least one amphiphilic compound and at least...
US20100310609 COMPOSITIONS AND METHODS FOR TREATMENT OF NEURODEGENERATIVE DISEASES  
Provided are electrokinetically-altered fluids (gas-enriched electrokinetic fluids) comprising an ionic aqueous solution of charge-stabilized oxygen-containing nanostructures in an amount...
US20080226736 Inhalatory Pharmaceutical Compositions in Form of Dry Powders, Solutions or Suspensions Obtained From the Same and Process for their Preparation  
Inhalatory pharmaceutical composition comprising a drug, a soluble excipient and a surfactant, characterized by: said soluble excipient is present in an amount between 10% and less than 100% by...
US20090298742 PROCESS FOR MANUFACTURING LACTOSE  
A process for forming crystalline lactose suitable for use in a pharmaceutical formulation comprises subjecting a solution comprising a plurality of nanosized lactose particles to conditions...
US20100120733 STEROID MODULATORS OF GLUCOCORTICOID RECEPTOR  
The present invention relates to new steroid modulators of glucocorticoid receptor activity, pharmaceutical compositions thereof, and methods of use thereof.
US20150118296 CONTROLLED RELEASE BUDESONIDE COMPOSITIONS  
The present invention relates to controlled release pharmaceutical compositions comprising budesonide. The invention also relates to processes for the preparation of such compositions and using...
US20070140980 Preparation of sterile aqueous suspensions comprising micronised crystalline active ingredients for inhalation  
Disclosed is a process for the preparation of sterile aqueous suspensions based on active ingredients in the form of micronised crystalline particles designed for administration by inhalation. In...
US20100212667 DRUG CAPSULES FOR DRY POWDER INHALERS  
A method of filling a drug capsule (2) for a dry powder inhaler comprising introducing a dose of powdered active substance (4) into the capsule and introducing a separate quantity of filler...
US20090169587 Chronotherapeutic dosage forms  
A chronotherapeutic pharmaceutical formulation comprising a core containing an active agent (e.g., a drug) and a surfactant and a delayed release compression coating comprising a natural or...
US20070134165 Use of Ciclesonide for the Treatment of Respiratory Disease in a Smoking Patient  
The invention relates to a new method of treatment of respiratory diseases, in particular the treatment of asthmatic smoking patients. The method comprises the administration of a pharmaceutical...
US20080241251 Method of Producing Microparticles  
A method of producing microparticles having a median diameter up to 100 μm and the microparticles so produced are described. The method includes the steps of providing a solvent having a bioactive...
US20090227548 Novel Glucocorticoid Receptor Agonists  
This Invention Relates To Novel Glucocorticoid Receptor Agonists of Formula (I): and to processes and intermediates for their preparation. The present invention also relates to pharmaceutical...
US20070197489 COMPOSITION OF MATTER  
The invention provides a process for the sterilization of a powdered form of a glucocorticosteroid, sterile glucocorticosteroids, sterile formulations containing glucocorticosteroids and use...
US20130267488 PHARMACEUTICAL FORMULATION HAVING NEUROPROTECTIVE ACTIVITY  
[Problem] The purpose of the present invention is to provide a neuroprotective agent which is capable of effectively protecting intraocular cells including optic nerves and is effective as a...
US20080139519 Heat Sterilization of Glucocorticosteroids  
The present invention provides a method for the sterilization of a labile glucocorticosteroid, which method comprises heat-treating by moist heat the labile glucocorticosteroid in the form of a...
US20130095146 CICLESONIDE CONTAINING AQUEOUS PHARMACEUTICAL COMPOSITION  
An aqueous pharmaceutical composition which comprises ciclesonide, crystalline cellulose carmellose sodium and hydroxypropylmethylcellulose is provided.
US20090143348 POLYSACCHARIDE GEL COMPOSITIONS AND METHODS FOR SUSTAINED DELIVERY OF DRUGS  
Methods of producing a biocompatible polysaccharide gel composition having sustained release properties are disclosed. Also disclosed is a biocompatible polysaccharide gel composition having...
US20140005132 CONTRACEPTIVE AGENTS  
The invention provides compounds of formula I, II, III, or IV: wherein R1 to R11, X, and Y have any of the values defined in the specification. The compounds inhibit Na, K-ATPase α4 and are useful...
US20100057047 DELIVERY DEVICE AND METHOD  
A nasal delivery device for and method of delivering substance to the middle meatus in a nasal cavity of a subject in the treatment of a condition, in particular an inflammatory or infectious...
US20110223216 Nanoparticles and Porous Particles and Methods of Making the Same  
The subject matter disclosed herein relates to compositions and methods for engineering porous particles for aerosol formulations for pulmonary drug delivery. Certain embodiments disclosed herein...
US20080207570 Topically applicable oil-in-water emulsions and dermatological applications thereof  
Novel topically applicable oil-in-water emulsions, with a high proportion of oily phase in the inner phase, combine the occlusive and emollient properties of an ointment without having the...
US20080306038 Compositions and Methods for Modulating Inflammation Using Fluoroquinolones  
Compositions for modulating an inflammation comprise a fluoroquinolone having one of Formulae I-VIII. Methods for modulating an inflammation comprise administering such compositions to a subject...
US20100087411 SUBSTITUTED SAPOGENINS AND THEIR USE  
The invention discloses substituted sapogenins and their use in the treatment of cognitive disfunction and similar conditions. Methods of treatment and pharmaceutical composition are also disclosed
US20110262368 C21 THIOETHERS AS GLUCOCORTICOID RECEPTOR AGONISTS  
The present invention provides compounds of Formula (VII) and 11-keto analogs thereof, and pharmaceutically acceptable salts, solvates, esters, prodrugs, tautomers, and isomers of said compounds...
US20050070515 Compounds  
Compounds capable of providing a therapeutic effect at a target site within a human or animal body with reduced systemic potency to said body are identified by comparing the susceptibility to...
US20090130176 INTRAOCULAR LENS WITH DRUG DELIVERY SYSTEM ATTACHED THERETO  
The present invention relates to a device comprising an intraocular lens and a drug delivery system attached thereto, wherein said drug delivery system is or can be loaded with one or more...
US20150133415 OPHTHALMIC COMPOSITIONS AND METHODS FOR TREATING OPHTHALMIC CONDITIONS  
Compositions, and methods of using such compositions, useful for placement, for example injection, into the interior of human or animal eyes are provided. Such compositions include a therapeutic...
US20080131518 Process for Preparing a Medicament  
The present invention provides a process for preparing a particulate medicament that has greater homogeneity and a lower adhesion between the particles of the active ingredient and the carrier....
US20110294766 16 Alpha, 17 Alpha-Acetal Glucocorticosteroidal Derivatives and their Use  
The present invention provides compounds of formula (I) wherein R1, R2, R3, R4, R5 and R6 are as defined in the specification, a process for their preparation, pharmaceutical compositions...
US20090048221 Conjugates with Anti-Inflammatory Activity  
Compounds represented by Formula I: wherein M represents a macrolide subunit of the substructure VIII: L represents the chain of the substructure IX or XIII: —X1—(CH2)m-Q-(CH2)n—X2— IX...
US20090143343 COMPOSITIONS FOR THE TREATMENT OF INFLAMMATION OF THE GASTROINTESTINAL TRACT  
Provided herein are methods for treating the symptoms of and inflammation associated with gastroesophageal reflux disease (GERD) and other conditions. Also provided herein are pharmaceutical...
US20100278931 POROUS SILICON DRUG-ELUTING PARTICLES  
The invention provides a biodegradable drug-eluting particle useful for the delivery of diagnostic or therapeutic agents. In certain embodiments, the drug-eluting particle of the invention...
US20080318843 Device and Method for the Delivery of Drugs for the Treatment of Posterior Segment Disease  
Hydrogel lenses are infused with a drug for the treatment of posterior segment disease. The lenses are placed in contact with the subject's cornea. Drugs can be passively released from the...
US20100119587 SOLID LIPIDIC PARTICLES AS PHARMACEUTICALLY ACCEPTABLE FILLERS OR CARRIERS FOR INHALATION  
The present invention relates to new compositions of (active) solid lipidic particles (SLP), e.g. for inhalation, and their use as carriers or as fillers in pharmaceutical compositions. It also...
US20120157373 ANTIMICROBIAL COMPOUNDS HAVING PROTECTIVE OR THERAPEUTIC LEAVING GROUPS  
Antimicrobial compounds, such as silanol or alcohol, include a protecting or leaving group that can protect the compound from degradation during the process of preparing a medical device...
US20100209508 Substituted Phenylphosphates as Mutual Prodrugs of Steroids and ß-Agonists for the Treatment of Title Pulmonary Inflammation and Bronchoconstriction  
A mutual prodrug of a corticosteroid and a substituted phenylphosphate (β-agonist derivative) for formulation for delivery by aerosolization to inhibit pulmonary inflammation and...

Matches 151 - 200 out of 297 < 1 2 3 4 5 6 >